EAM
SCMP

EverPoint Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

EverPoint Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.91M Buy
215,000
+15,000
+8% +$209K 0.05% 299
2016
Q3 		$2.46M Buy
+200,000
New +$2.36M 0.04% 330

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

EverPoint Asset Management's SCMP Position: Q4 2016 in Review

EverPoint Asset Management increased its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 7.5% in Q4 2016, buying an estimated $209K and bringing the position to 215,000 shares worth $2.91M. The position accounts for 0.05% of the portfolio, ranked #299.

EverPoint Asset Management first reported a position in SCMP in Q3 2016 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

  • EverPoint Asset Management held 215,000 shares of Sucampo Pharmaceuticals, Inc. worth $2.91M as of Q4 2016.
  • EverPoint Asset Management bought 15,000 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $209K.
  • Sucampo Pharmaceuticals, Inc. made up 0.05% of EverPoint Asset Management's portfolio in Q4 2016, its #299 holding.
  • EverPoint Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2016 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.